Tag: SORI
FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
40 percent of children achieved complete skin clearance at week 16 with Tremfya versus placebo
Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement
Authors say imaging may aid in identifying individuals at risk for progression to psoriatic arthritis
